Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
暂无分享，去创建一个
T. Hickish | I. Pedley | Robert J. Jones | D. Olmos | J. O’Sullivan | J. D. de Bono | V. Karavasilis | P. Fong | A. Omlin | L. R. Molife | K. Pelling | P. Jenkins | D. Wheatley | N. Oommen | G. Lumsden | D. Bloomfield | C. Heath | G. Temple | E. Thompson | J. D. de Bono | J. O’Sullivan | Peter C. Fong | Rob Jones | Rob J Jones